MedPath

Diabetes Scorecard Educational Intervention Study

Not Applicable
Completed
Conditions
Type 2 Diabetes
Registration Number
NCT01339520
Lead Sponsor
George Washington University
Brief Summary

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • Uncontrolled Type II diabetes (HbA1c ≥ 8%)
Exclusion Criteria
  • Type I Diabetes
  • HbA1c < 8%
  • Inability to understand the diabetes scorecard due to condition (i.e. dementia, mental retardation, etc) or language barrier
  • Pregnancy
  • Planning to move within the next year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in total score9 months

The total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.

Secondary Outcome Measures
NameTimeMethod
HbA1c9 months

Measure of glycemic control

LDL-cholesterol9 months

Trial Locations

Locations (1)

Medical Faculty Associates, George Washington University

🇺🇸

Washington, D.C., District of Columbia, United States

Medical Faculty Associates, George Washington University
🇺🇸Washington, D.C., District of Columbia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.